Format

Send to

Choose Destination
Acta Otolaryngol. 2008 Mar;128(3):272-6. doi: 10.1080/00016480701509933.

Screening for Menière's disease in the general population - the needle in the haystack.

Author information

1
Neurologische Klinik, Charité, Berlin, Germany. andre.radtke@charite.de

Abstract

CONCLUSION:

Based on clinical history alone, 98.4% of the population with vestibular vertigo do not qualify for a diagnosis of Menière's disease (MD). Although frequent in dizziness clinics, MD is rare in the general population.

OBJECTIVE:

To narrow down the prevalence of MD in the general population.

SUBJECTS AND METHODS:

A representative sample adult population sample (n=4869) was screened for moderate or severe dizziness/vertigo. Subsequently, 1003 participants completed a validated neurotologic telephone interview on vestibular vertigo (VV). Prevalence of MD was determined by stepwise application of clinical criteria according to the AAO (1995): (1) at least two vertigo attacks of > or =20 min duration, (2) unilateral hearing loss, and (3) accompanying cochlear symptoms.

RESULTS:

Lifetime prevalence of VV was 7.4%. Of 243 participants with VV, 51 (21%) had recurrent vertigo lasting > or =20 min. Of these, nine reported unilateral hearing loss, and four had accompanying cochlear symptoms (1.6% of VV patients, population prevalence 0.12%).

PMID:
18274913
DOI:
10.1080/00016480701509933
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center